EAG Laboratories, a global scientific services company that provides a broad range of testing services to technology-related industries, today announced the appointment of Duane Huggett, Ph.D., as Senior Scientific Advisor for the company’s environmental testing group.
Dr. Huggett provides scientific consultation and advice related to environmental fate and toxicology, with particular emphasis in the pharmaceutical and personal care product sectors. He has in-depth expertise related to endocrine (estrogen, androgen and thyroid) modulation and bioaccumulation assessments in wildlife.
"We are very excited to have Duane join our company," stated Siddhartha Kadia, President and CEO of EAG. “Duane brings a wealth of expertise and leadership experience. He understands environmental testing as well as the pharmaceutical and biotechnology industries. With his unique experience, along with his passion for environmental endeavors, he is a great fit for our company and our clients. After being a consultant in this space for many years, Duane is a great asset and will be an integral part of our value proposition.”
Prior to joining EAG, Dr. Huggett worked in contract laboratories, academia and industry. He began his career at Pfizer as part of an R&D team responsible for environmental risk assessments of new human health pharmaceuticals. Dr. Huggett designed and monitored acute and chronic ecotoxicological tests (e.g., invertebrates, fish, avian and plants) for new drug candidates. In addition, he reviewed and commented on assessments submitted to the U.S. Food and Drug Administration and the European Medicines Agency.
Dr. Huggett also served as a professor at the University of North Texas, teaching environmental science, toxicology and pharmacology, while also managing the university’s toxicology and chemistry lab. There he became actively involved in method development studies related to endocrine disruption, culturing fish, amphibians and aquatic invertebrates.
Most recently, Dr. Huggett performed toxicology and risk assessments at Waterborne Environmental, helping industrial clients with U.S. Environmental Protection Agency’s Endocrine Disruptor Screening Program evaluations as well as the European Union’s Registration, Evaluation, Authorisation and Restriction of Chemicals programs.
Dr. Huggett earned a Ph.D. in pharmacology and toxicology at the University of Mississippi, as well as an M.S. in biological sciences. He has participated in many national and international expert work groups and is a published author, co-author and editor of over 60 academic and scientific publications. Along with Bryan Brooks, he is co-editor of “Human Pharmaceuticals in the Environment, Current and Future Perspectives” (Springer Science & Business Media), exploring topics of environmental risk assessments and international regulations.
